Nature CommunicationsGenomicsPeer-reviewed journal article
Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features
Abstract
Tumor tissue of origin (TOO) is an important factor for guiding treatment decisions. However, TOO cannot be determined for ~3% of metastatic cancer patients and are categorized as cancers of unknown primary (CUP). As whole genome sequencing (WGS) of tumors is now transitioning from the research domain to diagnostic practice in order to address the increasing demand for biomarker detection, its use for detection of TOO in routine diagnostics also starts becoming within reach. While proof of concept for the use of genome-wide features has been demonstrated before, more complex WGS mutation features, including structural variant (SV) driver and passenger events, have never been integrated into TOO-classifiers even though they bear highly characteristic links with tumor TOO. Using a uniformly processed dataset containing 6820 whole-genome sequenced primary and metastatic tumors, we have developed Cancer of Unknown Primary Location Resolver (CUPLR), a random forest based TOO classifier that employs 502 features based on simple and complex somatic driver and passenger mutations. Our model is able to distinguish 33 cancer (sub)types with an overall accuracy of 91% and 89% based on cross-validation (n=6139) and hold out set (n=681) predictions respectively. We found that SV derived features increase the accuracy and utility of TOO classification for specific cancer types. To ensure that predictions are human-interpretable and suited for use in routine diagnostics, CUPLR reports the top contributing features and their values compared to cohort averages. The comprehensive output of CUPLR is complementary to existing histopathological procedures and may thus improve diagnostics for patients with CUP.
- organism: human
- assay: whole-genome sequencing
- research focus: differential expression
- research focus: variant calling
- research focus: benchmarking
- research focus: database / resource
- approach: machine learning (classical)
- Citations
- 84
- FWCI
- 7.63
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primary
Atara Posner, Owen W.J. Prall, … Richard W. Tothill·medRxiv·Jun 24, 2022
- A deep learning system can accurately classify primary and metastatic cancers based on patterns of passenger mutations
W. Jiao, G. Atwal, … ICGC/TCGA Pan-cancer Analysis of Whole Genomes Net·bioRxiv·Jan 22, 2019
- Development and Validation of OncoOrigin: An Integrative AI Tool for Primary Cancer Site Prediction
Petar Brlek, Luka Bulić, … Dragan Primorac·medRxiv·Nov 29, 2024
- Pan-cancer machine learning predictors of primary site of origin and molecular subtype
William F. Flynn, Sandeep Namburi, … Joshy George·bioRxiv·Jul 5, 2018
- Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients
Intae Moon, Jaclyn LoPiccolo, … Alexander Gusev·medRxiv·Dec 22, 2022
- Tumor Origin Detection with Tissue-Specific miRNA and DNA methylation Markers
Wei Tang, Shixiang Wan, … Quan Zou·BioinformaticsPeer-reviewed·Sep 27, 2017